ns 1619 has been researched along with Hypercholesterolemia in 1 studies
NS 1619: structure given in first source
NS 1619 : A member of the class of benzimidazoles that is 1,3-dihydro-2H-benzimidazol-2-one in which the hydrogens at positions 1 and 5 are replaced are replaced by 2-hydroxy-5-(trifluoromethyl)phenyl and trifluoromethyl groups, respectively. It is an opener/activator of the large-conductance calcium-activated potassium channel (Bkca).
Hypercholesterolemia: A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morikawa, K | 1 |
| Matoba, T | 1 |
| Kubota, H | 1 |
| Hatanaka, M | 1 |
| Fujiki, T | 1 |
| Takahashi, S | 1 |
| Takeshita, A | 1 |
| Shimokawa, H | 1 |
1 other study available for ns 1619 and Hypercholesterolemia
| Article | Year |
|---|---|
Influence of diabetes mellitus, hypercholesterolemia, and their combination on EDHF-mediated responses in mice.
Topics: Acetylcholine; Animals; Apolipoproteins E; Benzimidazoles; Biological Factors; Blood Glucose; Diabet | 2005 |